Ascletis Reports Superior ASC36_35 Weight Loss Data at EASD 2026
HONG KONG, July 23, 2026 Ascletis Pharma Inc. has announced that new preclinical data for its investigational obesity therapy...
preclinical study
Advertisement
INmune Targets Brain Injury-Linked Alzheimer’s
BOCA RATON, Fla., July 15, 2026 INmune Bio announced the publication of a peer-reviewed preclinical study in the Journal...
Artelo Biosciences Reports Positive ART26.12 Pain Data
SOLANA BEACH, Calif., July 1, 2026 Artelo Biosciences, Inc. announced positive preclinical data demonstrating that its investigational drug candidate...
LIR Shows Successful Needle-Free Delivery of GLP-1 Therapies
VANCOUVER, Canada, June 17, 2026 LIR Life Sciences Corp. announced the successful completion of its comparative preclinical animal study...
Nasus Pharma Reports Positive Preclinical Results for NS003
TEL AVIV, Israel, June 9, 2026 Nasus Pharma announced positive results from a preclinical pharmacokinetic (PK) and safety study...
Advertisements
Alcresta Therapeutics Shows RELiZORBneo Benefit Data
WALTHAM, Massachusetts, May 1, 2026 Alcresta Therapeutics, Inc. announced the publication of preclinical data evaluating its RELiZORBneo cartridge in...
Geminii Shows Promising NSCLC Data for Bioelectronic Therapy
CHICAGO, April 16, 2026 Geminii, Inc. has announced the presentation of new preclinical data on its bioelectronic therapy platform...
Innovent Showcases Tri-Specific Autoimmune Therapy Data
SAN FRANCISCO & SUZHOU, China, April 9, 2026 Innovent Biologics, Inc. has unveiled preclinical data for its novel tri-specific...
Coya’s COYA 303 Shows Promise in Neuroinflammation and Treg Boost
HOUSTON, Sept. 16, 2025 – Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company specializing in regulatory T cell...
Hoth Therapeutics Advances HT-KIT After Preclinical Breakthrough
NEW YORK, Sept. 2, 2025 – Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, announced encouraging preclinical results...
Advertisement
